Related Experiment Video
Updated: Feb 22, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
An empirically generated responder definition for rosacea treatment
Gerald Staedtler1, Kaweh Shakery2, Jan Endrikat3,4
1Bayer AG, Pharmaceutical Statistics.
A new responder definition for papulopustular rosacea treatment was established. Five or fewer lesions indicate a positive response, while six or more suggest a lack of response to therapy.
Area of Science:
- Dermatology
- Clinical Research
- Medical Science
Background:
- Papulopustular rosacea is a common facial skin condition.
- Defining treatment response is crucial for clinical practice and research.
- Current definitions may lack empirical validation.
Purpose of the Study:
- To empirically derive a clear responder definition for papulopustular rosacea treatment.
- To establish a quantifiable threshold for treatment success.
- To aid in the consistent evaluation of therapeutic interventions.
Main Methods:
- Analysis of 8 multicenter clinical studies involving 2,748 patients.
- Evaluation of treatments including azelaic acid and comparators.
- Utilized Investigator Global Assessment (IGA) and lesion counts for assessment.
Main Results:
- Responders averaged 2.23 lesions post-treatment (median 2).
- Non-responders averaged 13.74 lesions post-treatment (median 12).
- An optimal cutoff of 5.69 lesions was identified to differentiate responders from non-responders.
Conclusions:
- A threshold of 5.69 lesions effectively distinguishes treatment responders from non-responders.
- This definition aids in classifying patient outcomes for papulopustular rosacea.
- The findings support a more standardized approach to evaluating rosacea therapies.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020